BK0071 Pharmaceutical Business
- 751.890
- -9.961-1.31%
Shanghai Pharmaceuticals Holding Co., Ltd Goes Ex Dividend on Monday
Hunan Dajiaweikang Pharma to Raise $100 Million in Shenzhen IPO
06:14 PM EST, 11/25/2021 (MT Newswires) -- Hunan Dajiaweikang Pharmaceutical Industry (SHE:301126) has priced its initial public offering on the Shenzhen Stock Exchange's ChiNext board, seeking to ra
Hunan Dajiaweikang Pharma Launches Shenzhen IPO
06:08 PM EST, 11/15/2021 (MT Newswires) -- Hunan Dajiaweikang Pharmaceutical Industry (SHE:301126) has launched its initial public offering on the Shenzhen Stock Exchange's ChiNext board on Monday. T
China National Accord Medicines' Q3 Profit Falls 6.1%
03:39 AM EDT, 10/20/2021 (MT Newswires) -- China National Accord Medicines (SHE:000028) posted a 6.1% drop in net profit attributable to its shareholders to 332.7 million yuan ($52 million) in the th
Another province! Important subsidiaries of listed pharmaceutical companies have been assessed as "seriously" discredited because of bribery and cut-off supply.
A few days ago, the Henan Public Resources Trading Center issued a circular on the results of the evaluation of pharmaceutical prices and recruitment credits in our province (hereinafter referred to as "Notification"). According to the Bulletin, two pharmaceutical companies, Yichang Renfu Pharmaceutical Co., Ltd. and Beijing Baiao Pharmaceutical Co., Ltd., were rated as "serious" in Henan Province in terms of pharmaceutical prices and recruitment credits. In addition, four drugs of Yichang Renfu Pharmaceutical Co., Ltd. have commercial bribery in Henan Province. According to Tianyan check, Renfu Pharmaceutical and Sinopharmaceutical, a listed A-share company, own 80% and 20% of Yichang Renfu Pharmaceutical respectively. Renfu Pharmaceutical, the leading enterprise of pharmaceutical industry in Hubei Province, Chinese medicine.
6G is still being explored and is expected to be commercially available by 2030.
5G large-scale commercial is on its way, and 6G is also being proposed. September 17 news, yesterday, "2021 6G Symposium-6G Vision Outlook" was held in Beijing. The meeting said that 6G for commercial use in 2030 is still in the stage of vision requirements research and concept formation. At present, the global 6G development is still in the early stage, what is 6G, what is used for, what technology to achieve, are still in the process of exploration. However, the industry predicts that holographic communications, digital twins, immersive cloud XR and so on may become the main business applications of 6G. It is reported that the workers
Copy homework! These 10 shares are highly sought after by private equity! Which stocks did Feng Liu, Deng Xiaofeng, and Ge Weidong hold more than 60 billion dollars?
As the interim reports came to an end one after another, the latest holdings of many private equity bosses also gradually surfaced. By August 30, 1,633 private equity products had appeared in the list of the top ten tradable shareholders of listed companies. According to public data, with a market capitalization of 54 billion yuan, Gao Yi is far ahead. According to media statistics, Zijin Mining, Sany Heavy Industries, Yonghui Supermarket, Western Superconductor, Tianshan Aluminum, Huayou Cobalt, Wanda Film, Huarui 39, Hengli Hydraulic, and Sunwanda were the 10 largest new private equity markets in the second quarter. Meanwhile, the top ten largest private equity stocks were Maotai, Hikvision, Zijin Mining, and Ziguang Guowei, respectively
Baiyang Medicine: 21 institutions, including Tianfeng Securities and Minsheng Trust, investigated our company on August 29.
2021-08-31 Baiyang Pharmaceutical (301015) issued a notice saying: Tianfeng Securities Li Zhen, Yang Song, Minsheng Trust Jing Ying, Tianhong Fund Liu Mengmeng, Changsheng Fund Hao Zheng Zhang Weiguang, Shenzhen Hongding Wealth Liu Lulu, Beijing Ruishihong Zhang Peng, Taikang Asset Management Wang Xiaofeng, Guodu Securities Wang Yi, Hunan Yuansheng Investment Management, Tongfang Investment Xu Tonghui, Dongxing Securities Hu Boxin, Guangdong Hengsheng Fund Luojuan, Huaan Securities Li Changxing, NTF Asset New Tongfang Management Yang Tao, Ping an Fund Li Jie, Oriental Ronghui Asset Management FrancisJenkin, Bohai Huijin Asset Management Jigang
Read the picture and understand the civilian newspaper of Shuyu in 2021.
According to the report of Securities Star data Center, Shu Yu civilian 2021 showed that the company's main income was 2.479 billion yuan, up 10.26% from the same period last year; net profit from home was 86.9524 million yuan, up 22.8% from the same period last year; deducting non-net profit from 79.6267 million yuan, down 22.78% from the same period last year; debt ratio 54.31%, investment income-297800 yuan, financial expenses 11.7937 million yuan, gross profit 29.63%. There are 10 new shareholders in this period. Guangdong Province No. 3 Occupational annuity Plan-Bank of China Ltd. holds 34965 shares, accounting for 0.1% of tradable shares, China.
Ping an Life Insurance "self-insurance" results announced what to take to save the image of the insurance industry
The insurance industry has always had a bad image in the image of the common people. What is said before buying is good, and everything is guaranteed. When something goes wrong and claims are settled, there is no guarantee of this or that. Especially for those old people, the more they don't know much about insurance, the more they coax you into buying insurance. In recent years, this aspect of the news is not uncommon. Chaos occurs frequently not only for customers, but also within insurance companies. In the past, Guoshou employees posted a real-name report letter on Weibo Corp, reporting that the general manager of Guoshou Nenjiang Branch had problems such as premiums falsification, fraudulent insurance money for personal gain, and so on. Recently, another 11-year-old Ping an employee reported that he had been
Sichuan Hezong Medicine to List 1.25% Stake as IPO Lockup Ends; Shares Slump 7%
11:55 PM EDT, 07/25/2021 (MT Newswires) -- Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SHE:300937) will unlock 1.2 million shares representing 1.25% of the company's share capital on Tuesday.
The announcement of four companies on July 22nd was unfavorable: shareholders of Hupu shares intend to reduce their holdings by no more than 2%.
It is announced that the shareholders of Houpu shares intend to reduce their holdings of no more than 2% of the shares of Houpu shares. Jiang Tao, the shareholder who holds 38356323 shares of the company (accounting for 10.52% of the total share capital of the company), plans to reduce his holdings of no more than 7294400 shares of the company (not more than 2.00% of the total share capital of the company) within 6 months after 15 trading days from the date of the announcement. And the total number of shares reduced for 90 consecutive natural days shall not exceed 1% of the total number of shares of the company. Baoli new shareholder Jianrui Penghua partnership or passive reduction of no more than 7.08% of the company's shares Baoli new announcement, the company holds more than 5% of the shareholders of Xi'an.
Fund position trend: Jingshun Great Wall Fund Yu Guang increased its position in these stocks in the second quarter (list)
Zheng Xing Research Institute, on July 21, Jingshun Great Wall Fund Yu Guang's fund announced the China report, summing up the financial results of its funds, the proportion of Hong Kong stocks decreased significantly, Tencent Holdings, Si Moore International and so on were reduced; in addition, the individual stocks of the new energy automobile industry sector attracted more attention. Compared with the last quarter, Xin Wanda and others were increased, and New Zebang, Xingyuan material, Changan Automobile and other new positions entered the top ten positions. The small home appliance industry sector has been reduced, Gree Electric Appliances and others have withdrawn from the top ten heavy positions, and Stone Technology has been reduced; at present, the top three comprehensive positions of its funds are Vivia Biology, Poly Xiexin Energy, and New Zebang. Fund heavy stock change
DaShenLin's Earnings May Be Fueled by Store Expansion -- Market Talk
DJ DaShenLin's Earnings May Be Fueled by Store Expansion -- Market Talk 0349 GMT - DaShenLin Pharmaceutical's profit may rise this year, as it accelerates its store expansion with a target of 2,00
LBX Pharmacy Chain Initiated with CNY88 Price Target by Daiwa Capital>603883.SH
*DJ LBX Pharmacy Chain Started at Outperform by Daiwa Capital >603883.SH (MORE TO FOLLOW) Dow Jones Newswires January 17, 2021 20:56 ET (01:56 GMT) *DJ LBX Pharmacy Chain Initiated with CN
DaShenLin Pharmaceutical Started at Buy by Daiwa Capital >603233.SH
*DJ DaShenLin Pharmaceutical Started at Buy by Daiwa Capital >603233.SH (MORE TO FOLLOW) Dow Jones Newswires January 17, 2021 20:33 ET (01:33 GMT) Copyright (c) 2021 Dow Jones & Compan
*DJ Shanghai Pharma Holding Unveils Stk Option Incentive Plans 'to Accelerate Restructuring and Boost Global Competitiveness' >2607.HK
Press Release: Shanghai Pharma Unveils Stock Incentive Plans to Accelerate Global Ambition Shanghai Pharma Unveils Stock Incentive Plans to Accelerate Global Ambition PR Newswire SHANG